ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,269Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 198

$533K Total Retail Price of All Prescriptions

Rank: 51 out of 198

595 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 595 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 595 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 13,133 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
OMEPRAZOLE 688 628 1 3
WARFARIN SODIUM 683 665 2 7
SIMVASTATIN 646 564 3 2
LEVOTHYROXINE SODIUM 575 527 4 1
METOPROLOL TARTRATE 572 543 5 10
LISINOPRIL 469 458 6 6
FUROSEMIDE 450 435 7 5
POTASSIUM CHLORIDE 436 418 8 9
METOPROLOL SUCCINATE 424 414 9 11
METFORMIN HCL 397 365 10 13
HYDROCODONE-ACETAMINOPHEN 349 313 S3 11 8
AMLODIPINE BESYLATE 344 327 12 4
BISOPROLOL-HYDROCHLOROTHIAZIDE 283 261 13 127
ATENOLOL 199 173 14 17
HYDROCHLOROTHIAZIDE 197 192 15 16
DIGOXIN 190 190 16 43
TRIAMTERENE-HCTZ 188 179 17 32
ATORVASTATIN CALCIUM 170 165 18 12
CITALOPRAM HBR 164 162 19 20
PREDNISONE 157 139 20 29
SERTRALINE HCL 152 134 21 25
ENALAPRIL MALEATE 143 131 22 51
PAROXETINE HCL 138 128 23 65
DONEPEZIL HCL 130 130 24 28
ALLOPURINOL 128 126 25 23
CRESTOR 123 116 26 26
TAMSULOSIN HCL 122 102 27 27
ALENDRONATE SODIUM 116 116 28 21
CARBIDOPA-LEVODOPA 111 111 29 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 110 29 38
TERAZOSIN HCL 99 77 31 102
LOSARTAN POTASSIUM 95 89 32 18
DILTIAZEM ER 94 91 33 98
CLONIDINE HCL 92 91 34 52
CLOPIDOGREL 90 78 35 42
TRAMADOL HCL 87 74 36 15
ZOLPIDEM TARTRATE 86 74 37 22
AZITHROMYCIN 81 71 38 56
GLIMEPIRIDE 75 75 39 35
PRAVASTATIN SODIUM 73 63 40 19
CARVEDILOL 72 72 41 24
FAMOTIDINE 71 59 42 57
ISOSORBIDE MONONITRATE ER 69 68 43 60
NAMENDA 68 68 44 33
NOVOLOG 65 54 45 107
SPIRONOLACTONE 64 34 46 37
PLAVIX 64 54 46 66
LANTUS 64 54 46 46
RAMIPRIL 60 60 49 72
AMIODARONE HCL 57 57 50 119
SPIRIVA 56 50 51 63
LANTUS SOLOSTAR 55 42 52 85
RISPERIDONE 55 52 52 82
FENTANYL 54 46 S2 54 73
POLYETHYLENE GLYCOL 3350 53 53 55 41
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 56 49
MECLIZINE HCL 50 50 56 129
OXYBUTYNIN CHLORIDE 50 44 56 89
CIPROFLOXACIN HCL 50 41 56 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.